Veterinary Medicines

Damtix 2000 mg/400 mg spot-on solution for dogs over 25 kg

Authorised
  • Imidacloprid
  • Permethrin (40:60)
Download as PDF

Product identification

Medicine name:
Damtix 2000 mg/400 mg spot-on solution for dogs over 25 kg
DAMTIX 2000 mg/400 mg soluzione spot-on per cani oltre 25 kg
Active substance:
  • Imidacloprid
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    400.00
    milligram(s)
    /
    1.00
    Pipette
  • Permethrin (40:60)
    2000.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 10 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 6 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 4 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 3 pipettes
  • White polypropylene pipette closed with a polyethylene (HDPE) cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 6 ml pipette containing 4.0 ml of solution Box containing 1 pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105613
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0663/004
Concerned member states:
  • Finland
  • France
  • Germany
  • Greece
  • Italy
  • Portugal
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 31/05/2024
Download

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."